02373nas a2200241 4500000000100000008004100001653002600042653001400068653001200082653001000094653001300104100001400117700001300131700001200144700001200156700001200168700001200180245012600192856004300318300001200361490000600373520175200379 2015 d10aRetrospective Studies10aPathology10aleprosy10aIndia10aclinical1 aShirazi N1 aJindal R1 aAhmad S1 aRawat S1 aSelvi T1 aHarsh M00aClinico Pathological Correlation of Leprosy: A 4 Years Retrospective Study from a Tertiary Referral Centre in North India uhttp://ijmrhs.com/42/18%20Nadia%20etal a350-3540 v43 a

Introduction: Leprosy is a chronic infectious disease caused by Mycobacterium leprae that primarily affects the skin and nerves. The histopathological findings in leprosy are related to the immunological status of the patient.
Aim: To tabulate the incidence of different clinical and pathological patterns of leprosy and establish their correlation.
Materials and Methods: A total of 118 consecutive skin biopsies of leprosy patients were studied in the Department of Pathology over 4 year duration (2010 – 2014). A Ridley-Jopling criterion was used for the diagnosis and classification of the disease. All biopsies were stained with H&E and Fite Faraco. Clinico-histopathological correlation was calculated using percentage values.
Results: A total of 118 cases of leprosy were studied out of which 76 were males. The age of the patients ranged from 8 years to 76 years. Majority were in the 31-40 year age group ( n= 52.44%). Both clinically (n=55, 46.6%) and histologically (n=41, 34.7%), the maximum patients were in the BT category. Histopathologically LL (21.2%) and BB (16.1%) were the other common groups. The overall concordance between clinical and histopathological classification was 61.8%. Maximum concordance was seen in LL (79.2%) & TT (72.7%). The concordance was lower in borderline groups and least in BL (18.7%). Fite Faraco stain demonstrated acid fast bacilli in 28 cases (23.7%).
Conclusion: The clinicohistopathological correlation is best at the polar ends of spectrum as compared to borderline cases. Histopathology remains the most powerful indicator of shift in patient’s immune status.